1054644-79-9

Basic information

• Product Name: Hexacosanoic acid ((1S,2S,3R)-2,3-bis-benzyloxy-1-benzyloxymethyl-heptadecyl)-amide
• Synonyms: Hexacosanoic acid ((1S,2S,3R)-2,3-bis-benzyloxy-1-benzyloxymethyl-heptadecyl)-amide
• CAS NO: 1054644-79-9
• Molecular Weight: 966.569
• Mol File: 1054644-79-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Hexacosanoic acid ((1S,2S,3R)-2,3-bis-benzyloxy-1-benzyloxymethyl-heptadecyl)-amide(CAS DataBase Reference)
• NIST Chemistry Reference: Hexacosanoic acid ((1S,2S,3R)-2,3-bis-benzyloxy-1-benzyloxymethyl-heptadecyl)-amide(1054644-79-9)
• EPA Substance Registry System: Hexacosanoic acid ((1S,2S,3R)-2,3-bis-benzyloxy-1-benzyloxymethyl-heptadecyl)-amide(1054644-79-9)

Safety Data

• Hazardous Substances Data: 1054644-79-9(Hazardous Substances Data)

Upstream product

• 164988-68-5 (2R,3S,4R)-1,3,4-Tris-benzyloxy-octadecan-2-ol 
• 129831-88-5 (2R,3S,4R)-1,3,4-tri-O-benzyl-2-O-methansulfonyl-1,2,3,4-octadecanetetraol 
• 129779-76-6 (2S,3S,4R)-1,3,4-tri-O-benzyl-2-azido-1,3,4-octadecanetriol 
• 165172-26-9 (2R,3S,4R)-1,3,4-tri-O-benzyl-5-octadecene-1,2,3,4-tetraol 
• 115563-43-4 (2S,3S,4R)-2,3,5-tribenzyloxy-4-hydroxypentanal 
• 13266-02-9 n-tridecyltriphenylphosphonium bromide 
• 20672-66-6 3,4,5-tri-O-benzyl-D-galactopyranose 
• 765-09-3 1-bromotridecane 
• 506-46-7 1-hexacosanoic acid 
• 129779-77-7 (2S,3S,4R)-1,3,4-tri-O-benzyl-2-amino-1,3,4-octadecanetriol 

Downstream Products

• 209899-67-2 (2S,3S,4R)-2-(N-hexacosanoylamino)-3,4-di-O-benzoyl-1-O-(triphenylmethyl)-1,3,4-octadecanetriol 
• 1053701-00-0 (2S,3S,4R)-2-(N-hexacosanoylamino)-1-O-(triphenylmethyl)-1,3,4-octadecanetriol 
• 209899-68-3 (2S,3S,4R)-2-(N-hexacosanoylamino)-3,4-di-O-benzoyl-1,3,4-octadecanetriol 

Relevant articles and documents

Structure-activity relationship of α-galactosylceramides against b16- bearing mice

Agelasphin-9b, (2S,3S,4R)-1-O-(α-D-galactopyranosyl)-16-methyl-2-[N- ((R)-2-hydroxytetracosanoyl)-amino]-1,3,4-heptadecanetriol, is a potent antitumor agent isolated from the marine sponge Agelas mauritianus. Various analogues of agelasphin-9b (a lead compound) were synthesized, and the relationship between their structures and biological activities was examined using several assay systems. From the results, KRN7000, (2S,3S,4R)-1-O-(α- D-galactopyranosyl)-2-(N-hexacosanoylamino)-1,3,4-octadecanetriol, was selected as a candidate for clinical application.